Biogen Inc
Sector: Manufacturing
Industry: Pharmaceutical Products
142.43
3.27
(2.35%)
Volume:
1,514,616
52 week range:
128.51 - 238.00
Market Cap:
20.848B
Company Description:
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis. It also offers RITUXAN for treating non-Hodgkin's lymphoma, chronic lymphocytic leukemia (CLL), rheumatoid arthritis, and pemphigus vulgaris.